SCHEMBL6308113

SCHEMBL6308113

CC[SiH](CC)CC.CC[SiH](CC)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4309 1.00
Bromide SCHEMBL9240812 0.94
Hydrochloric Acid SCHEMBL971324 0.94
SCHEMBL5707642 0.94
Water SCHEMBL7852378 0.94
SCHEMBL9780539 0.94
SCHEMBL5014799 0.94
SCHEMBL18575052 0.94
SCHEMBL2911593 0.94
Hydrochloric Acid SCHEMBL3505113 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3684877-A1 SILSESQUIOXANE POLYMERS, COMPOSITIONS, AND ARTICLES 3M Innovative Properties Company (US) 2020-07-29 EP disclosed
WO-2019058232-A1 SILSESQUIOXANE POLYMERS, COMPOSITIONS, AND ARTICLES 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-03-28 WO disclosed
US-6943189-B2 Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG CO-A reductase inhibitors G.D. SEARLE & CO. (US) 2005-09-13 US disclosed
US-20040157915-A1 Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors G.D. SEARLE & CO. (US) 2004-08-12 US disclosed